擅長:
一、基本情況
神經外科副主任醫(yī)師、碩士研究生導師、臨床醫(yī)學博士。2016-2018年國家公派至美國常春藤名校賓夕法尼亞大學學習。主持國家自然科學基金、廣東省青年基金等,以第一/共同第一作者在《Nature Communications》、《Genome Medicine》、《中華醫(yī)學雜志(英文版)》等國內外著名期刊發(fā)表學術論文20余篇,授權發(fā)明專利3項、實用新型專利6項,多次在美國及歐洲神經腫瘤會議作學術報告。長期與美國賓夕法尼亞大學、英國劍橋大學、中國香港大學、四川華西醫(yī)院等國內外知名院校專家保持學術交流合作。出診時間:星期二下午。
?
二、教育及工作經歷
1. 2024-01 至今,中山大學腫瘤防治中心神經外科,副主任醫(yī)師
2. 2023-01 至 2023-12,中山大學腫瘤防治中心神經外科,主治醫(yī)師
3. 2020-07 至 2022-12,中山大學腫瘤防治中心神經外科,住院醫(yī)師,博士后?
4. 2015-09 至 2020-06, 中山大學, 臨床醫(yī)學博士
5. 2016-11 至 2018-10, 美國賓夕法尼亞大學, 聯(lián)合培養(yǎng)博士
6. 2012-09 至 2015-06, 中山大學, 臨床醫(yī)學碩士
7. 2007-09 至 2012-06, 哈爾濱醫(yī)科大學, 臨床醫(yī)學學士
?
三、主持科研項目
1. 國家自然科學基金,青年項目,纖溶酶原對骨髓間充質干細胞促進膠質母細胞瘤進展的調控及機,82303805,30 萬元,2024-01 至 2026-12;
2. 廣東省基礎與應用基礎研究基金項目,區(qū)域聯(lián)合基金-青年基金項目,DCPS抑制劑RG3039抗膠質母細胞瘤的機制研究,2020A1515110069,10萬元,2020-10至2023-09;
3. 中山大學腫瘤防治中心,易方達“郁金香”優(yōu)秀人才培養(yǎng)基金,纖溶酶原激活HGF/c-Met通路促進間充質干細胞介導的膠質母細胞瘤進展的研究, 2022-01至2023-12,5萬元。
?
四、代表性論著
1. H. Duan# (共一排第一), J. Ren#, S. Wei#, Z. Yang#, C. Li#, Z. Wang#, M. Li#, Z. Wei*, Y. Liu, X. Wang, H. Lan, Z. Zeng, M. Xie, Y. Xie, S. Wu, W. Hu, C. Guo, X. Zhang, L. Liang, C. Yu, Y. Mou, Y. Jiang, H. Li, E. Sugarman, R. A. Deek, Z. Chen, T. Li, Y. Chen*, M. Yao*, L. Chen*, L. Liu*, G. Zhang* and Y. Mou* (2024). Integrated analyses of multi-omic data derived from paired primary lung cancer and brain metastasis reveal the metabolic vulnerability as a novel therapeutic target. Genome Med 16(1): 138.?(IF=10.4)
2. H. Duan# (共一排第一), Y. Xie#, S. Wu#, G. Zhao#, Z. Zeng, H. Hu, Y. Yu, W. Hu, Y. Yang, Y. Chen, H. Xie, Z. Chen, G. Zhang, K. T. Flaherty, S. Hu, H. Xu*, W. Ma* and Y. Mou* (2024). Effect of the mRNA decapping enzyme scavenger (DCPS) inhibitor RG3039 on glioblastoma. J Transl Med 22(1): 880.?(IF=6.1)
3. H. Duan# (共一排第一), Z. He#, Z. Chen#, Y. Chen#, W. Hu, K. Sai, X. Zhang, J. Xia, Y. Li, R. Liu, C. Zou, Z. Chen and Y. Mou* (2024). Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up. BMC Immunol 25(1): 83.??(IF=2.9)
4. R. Cui#, H. Duan#?(共一排第二), W. Hu#, C. Li, S. Zhong, L. Liang, S. Chen, H. Hu, Z. He, Z. Wang, X. Guo, Z. Chen, C. Xu, Y. Zhu, Y. Chen, K. Sai, Q. Yang, C. Guo*, Y. Mou* and X. Jiang* (2024). Establishment of Human Pituitary Neuroendocrine Tumor Derived Organoid and Its Pilot Application for Drug Screening. J Clin Endocrinol Metab.?(IF=5.0)
5. Y. Zou#, H. Duan#?(共一排第二), Z. Deng#, R. Xiang#, J. Zhao, Z. Zhang, W. Hu, Y. Yang, Z. Yan, S. Wen, Z. Liu, G. Zhang*, Y. Mou*, D. Li* and X. Jiang* (2024). Single-cell atlas profiling revealed cellular characteristics and dynamic changes after PD-1 blockade therapy of brain metastases from laryngeal squamous cell carcinoma. Mol Cell Biochem.?(IF=3.5)
6. Lanyang Xu#, Hao Duan#?(共一排第二), Yuheng Zou#, Jing Wang, Huaxi Liu, Wanyu Wang, Xiao Zhu, Jiali Chen, Chuanwu Zhu, Zhixin Yin, Xiaoshan Zhao*, Qirui Wang*, Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2. Phytomedicine, 2023-06-01, 114:154764. ?(IF=7.9)
7. Lun Liang#, Liangbao Wen#, Shixing Qin#, Zhenqiang He, Jie Lu, Run Cui, Xiaobing Jiang, Hongrong Hu, Sheng Zhong, Chang Li, Chengwei Yu, Yuang Xie, Zhenning Wang*, Hao Duan* (共同通訊作者), Yonggao Mou*, Poor Karnofsky performance status is not a contraindication for neurosurgical resection in patients with lung cancer brain metastases: a multicenter, retrospective PSM- IPTW cohort study. Journal of Neuro-oncology, 2023-03-20, 162, (2):327-335. (IF=3.9)
8. Jiahao Bao#;?Weicheng Lu#; Hao Duan# (共一排第三); Yaqi Ye; Jiangbo Li; Wenting Liao; Yongchun Li; Yangpeng Sun: Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas, Front Immunol. 2022 Aug 15;13:933973.?(IF=8.78)
9. Suwen Wu#; Chune Gan#; Xiaoling Huang#; Dongping Jiang; Ye Xu; Yixia Liao; Fen Ma; Yutong Hong; Hao Duan?(通訊作者); Peng Lin: Incidence and risk factors of postoperative nausea and vomiting in lung cancer patients following lobectomy and application of analgesic pumps, J Int Med Res. 2022 Jun;50(6):3000605221105343.?(IF=1.57)
10. Hao Duan# (共一排第一); Xiaobing Jiang#; Chang Li#; Mingyuan Chen; Bei Zhang; Yuanyuan Huang; Qingyu Zhao; Yonggao Mou: Application of a three-dimensional printed model to localize a cranial cerebrospinal fluid leak: a case report, J Int Med Res. 2022 Feb;50(2):3000605221078412. (IF=1.57)
11. Wanming Hu#; Hao Duan# (共一排第二); Sheng Zhong#; Jing Zeng; Yonggao Mou; High frequency of PDGFRA and MUC family gene mutations in diffuse hemispheric glioma, H3 G34-mutant: a glimmer of hope?, Journal of Translational Medicine, 2022, 20(1): 0-64. (IF=8.44)
12. Fan Yang#; Zhenqiang He#; Hao Duan# (共一排第三); Duo Zhang; Juehui Li; Huijuan Yang; Jay F Dorsey; Wei Z ou; S Ali Nabavizadeh; Stephen J Bagley; Kalil Abdullah; Steven Brem; Lin Zhang; Xiaowei Xu; Kate lyn T Byrne; Robert H Vonderheide; Yanqing Gong; Yi Fan ; Synergistic immunotherapy of glioblasto ma by dual targeting of IL-6 and CD40, Nature Communications, 2021, 12. (IF=17.70)
13. Liling Liu#; Yuanzhong Yang#; Hao Duan# (共一排第三); Jiahua He; Lu Sun; Wanming Hu; Jing Zeng: CHI3L2 Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Gliomas, Frontiers in Oncology. 2021 Apr 15;11:611038. (IF=5.74)
14. Luqiang Wang#; Lutian Yao#; Hao Duan#?(共一排第三); Fan Yang; Maohuan Lin; Rongxin Zhang; Zhenqiang He; J aimo Ahn; Yi Fan; Ling Qin; Yanqing Gong ; Plasminogen Regulates Fracture Repair by Promoting the Functions of Periosteal Mesenchymal Progenitors, Journal of Bone and Mineral Research, 2021.11, 3 6(11): 2229-2242. (IF=6.39)
15. Hao Duan#?(共一排第一); Zhenqiang He#; Maohuan Lin; Yanling Wang; Fan Yang; R. Alan Mitteer; Hyun-Jun Ki m; Eujing Yeo; Hongyu Han; Ling Qin; Yi Fan; Yanqing Gong; Plasminogen regulates mesenchymal ste m cell-mediated tissue repair after ischemia through Cyr61 activation, JCI INSIGHT, 2020, 5(15): 0-e131376. (IF=9.48)
16. Hao Duan#?(共一排第一); Jilong Hu#; Zhenghe Chen; Juehui Li; Zhenqiang He; Zhenning Wang; Guanhua Zhang; Xiaoyu Guo; Lun Liang; Yonggao Mou; Assessment of circulating tumor DNA in cerebrospinal fluid by whole exome sequencing to detect genomic alterations of glioblastoma, Chinese Medical Journal, 2020;133(12). (IF=6.13)
17. Depei Li#; Hao Duan#(共一排第二); Pingping Jiang; Xiaobing Jiang; Zhenqiang He; Chengcheng Guo; Yonggao Mou: Trend and socioeconomic disparities in survival outcome of metastatic melanoma after approval of immune checkpoint inhibitors: a population-based study, Am J Transl Res. 2020 Jul 15;12(7):3767-3779. (IF=3.94)
?
五、獲獎及榮譽
第六屆廣東醫(yī)學科技獎一等獎
?
?
更新時間:2025.02.08
預約掛號